Psychiatric Disorders and Sleep

Neurologic Clinics

Volumn 30, Issue 4, 2012, Pages 1389-1413

  Krystal, Andrew D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anxiety; Depression; Insomnia; Psychiatric disorders; Sleep; Substance use disorders

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; DOXEPIN; ESCITALOPRAM; ESZOPICLONE; FLUOXETINE; GABAPENTIN; HALOPERIDOL; LITHIUM; LORMETAZEPAM; MAPROTILINE; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PRAZOSIN; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TRAZODONE; TRIMIPRAMINE; UNINDEXED DRUG; ZIPRASIDONE; ZOLPIDEM;

ALCOHOLISM; ANXIETY; BEDTIME DOSAGE; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERSOMNIA; INSOMNIA; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SUBSTANCE ABUSE; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;

ADULT; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MENTAL DISORDERS; SLEEP; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 84867912336     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2012.08.018     Document Type: Review

References (197)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, 4th edition, text revision, APA, Washington, DC.
2. Krystal A.D. A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice. Sleep Med Rev 2009, 13(4):265-274.
3. Walsh J.K., Schweitzer P.K. Ten-year trends in pharmacologic treatment of insomnia. Sleep 1999, 22:371-375.
4. Thorpy M. Current concepts in the etiology, diagnosis and treatment of narcolepsy. Sleep Med 2001, 2:5-17.
5. Santosh P.J., Taylor E. Stimulant drugs. Eur Child Adolesc Psychiatry 2000, 9(Suppl 1):127-143.
6. Nierenberg A.A., Dougherty D., Rosenbaum J.F. Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry 1998, 59(Suppl 5):60-63.
7. Bakshi R. Fluoxetine and restless legs syndrome. J Neurol Sci 1996, 142(1-2):151-152.
8. Baran A.S., Richert A.C. Obstructive sleep apnea and depression. CNS Spectr 2003, 8:128-134.
9. Giedke H., Schwarzler F. Therapeutic use of sleep deprivation in depression. Sleep Med Rev 2002, 6:361-377.
10. Thase M.E. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry 1999, 60(Suppl 17):28-31.
11. Waller D.A., Hardy B.W., Pole R., et al. Sleep EEG in bulemic, depressed and normal subjects. Biol Psychiatry 1989, 25:661-664.
12. Kupfer D.J., Ulrich R.F., Coble P.A., et al. Electroencephalographic sleep of younger depressives. Arch Gen Psychiatry 1985, 42:806-810.
13. Gillin J.C., Duncan W.C., Pettigrew K.D., et al. Successful separation of depressed, normal and insomniac subjects by EEG sleep data. Arch Gen Psychiatry 1979, 36:85-90.
14. Berger M., Doerr P., Lund R.D., et al. Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?. Biol Psychiatry 1982, 17:1217-1242.
15. Kupfer D.J., Foster F.G. Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet 1972, 2:684-686.
16. Kupfer D.J., Reynolds C.F., Ehlers C.L. Comparison of EEG sleep measures among depressive subtypes and controls in older individuals. Psychiatry Res 1989, 27:13-21.
17. Kupfer D.J., Ulrich R.F., Coble P.A., et al. Application of automated REM and slow-wave sleep analysis, II: testing the assumptions of the two-process model of sleep regulation in normal and depressed subjects. Psychiatry Res 1985, 13:335-343.
18. Snyder F. Dynamic aspects of sleep disturbance in relation to mental illness. Biol Psychiatry 1969, 1:119-130.
19. Hartmann E., Verdone P., Snyder F. Longitudinal studies of sleep and dreaming patterns in psychiatric patients. J Nerv Ment Dis 1966, 142:117-126.
20. Mendels J., Hawkins D.R. Sleep and depression: a controlled EEG study. Arch Gen Psychiatry 1967, 16:344-354.
21. Benca R.M., Obermeyer W.H., Thisted R.A., et al. Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 1992, 49:651-668.
22. Quitkin F.M., Rabkin J.G., Stewart J.W., et al. Sleep of atypical depressives. J Affect Disord 1985, 8:61-67.
23. Emslie G.J., Rush A.J., Weinberg W.A., et al. Children with major depression show reduced rapid eye movement latencies. Arch Gen Psychiatry 1990, 47:119-124.
24. Jones D.A., Kelwala S., Bell J., et al. Cholinergic REM sleep induction response correlation with endogenous depressive subtype. Psychiatry Res 1985, 14:99-110.
25. Foster F.G., Kupfer D.J., Coble P.A., et al. Rapid eye movement sleep density. An objective indicator in severe medial-depressive syndromes. Arch Gen Psychiatry 1976, 33:1119-1123.
26. Borbely A.A., Tobler I., Loepfe M., et al. All night spectral analysis of the sleep EEG in untreated depressives and normal controls. Psychiatry Res 1984, 12:27-33.
27. Feinberg M., Gillin J.C., Carroll B.J., et al. EEG studies of sleep in the diagnosis of depression. Biol Psychiatry 1982, 17:305-316.
28. Kupfer D.J., Reynolds C.F., Ulrich R.F., et al. Comparison of automated REM and slow wave sleep analysis in young and middle-aged depressed subjects. Biol Psychiatry 1986, 21:189-200.
29. Giles D.E., Etzel B.A., Reynolds C.F., et al. Stability of polysomnographic parameters in unipolar depression: a cross-sectional report. Biol Psychiatry 1989, 25:807-810.
30. Thase M.E., Fasiczka A.L., Berman S.R., et al. Electroencephalographic sleep profiles before and after cognitive behavioral therapy of depression. Arch Gen Psychiatry 1998, 55:138-144.
31. Hauri P.J., Chernic D., Hawkins D.R., et al. Sleep of depressed patients in remission. Arch Gen Psychiatry 1974, 31:386-391.
32. Rush A.J., Erman M.K., Giles D.E., et al. Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry 1986, 43:878-884.
33. Lee J.H., Reynolds C.F., Hoch C.C., et al. Electroencephalographic sleep in recently remitted, elderly depressed patients in double-blind placebo maintenance therapy. Neuropsychopharmacology 1993, 8:143-150.
34. Schulz H., Lund R.D., Cording C., et al. Bimodal distribution of REM sleep latencies in depression. Biol Psychiatry 1979, 14:595-600.
35. Kerkhofs M., Hoffman G., De Martelaere V., et al. Sleep EEG recordings in depressive disorders. J Affect Disord 1985, 9:47-53.
36. Wehr T.A., Sack D.A., Rosenthal N.E. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 1987, 144:201-204.
37. Nofzinger E.A., Thase M.E., Reynolds C.F., et al. Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test. Am J Psychiatry 1991, 148:1177-1181.
38. Hudson J.I., Lipinski J.F., Frankenburg F.R., et al. Electroencephalographic sleep in mania. Arch Gen Psychiatry 1988, 45:267-273.
39. Linkowski P., Kerkhofs M., Rielaert C., et al. Sleep during mania in manic-depressive males. Eur Arch Psychiatry Neurol Sci 1986, 235:339-341.
40. Monti J.M., Monti D. Sleep disturbance in generalized anxiety disorder and its treatment. Sleep Med Rev 2000, 4:263-276.
41. Reynolds C.F., Shaw D.H., Newton T.F., et al. EEG sleep in outpatients with generalized anxiety: as preliminary comparison with depressed outpatients. Psychiatry Res 1983, 8:81-89.
42. Uhde T.W. Anxiety disorders. Principles and practice of sleep medicine 2000, 1123-1139. W.B. Saunders. 3rd edition. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
43. Saletu B., Anderer P., Brandstätter N., et al. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). Neuropsychobiology 1994, 29(2):69-90.
44. Fuller K.H., Waters W.F., Binks P.G., et al. Generalized anxiety and sleep architecture: a polysomnographic investigation. Sleep 1997 May, 20(5):370-376.
45. Ross R.J., Ball W.A., Sullivan K.A., et al. Sleep disturbance as the hallmark of posttraumatic stress disorder. Am J Psychiatry 1989, 146:697-707.
46. Mellman T.A., Kulick-Bell R., Ashlock L.E., et al. Sleep events among veterans with combat-related posttraumatic stress disorder. Am J Psychiatry 1995, 152:110-115.
47. Mellman T., Kumar A., Kulick-Bell R., et al. Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol Psychiatry 1995, 38:174-179.
48. Mellman T.A., Nolan B., Hebding J., et al. A polysomnographic comparison of veterans with combat-related PTSD, Depressed men, and non-ill controls. Sleep 1997, 20:46-51.
49. Dow B.M., Kelsoe J.R., Gillin J.C. Sleep and dreams in Vietnam PTSD and depression. Biol Psychiatry 1996, 39:42-50.
50. Kobayashi I., Huntley E., Lavela J., et al. Subjectively and objectively measured sleep with and without posttraumatic stress disorder and trauma exposure. Sleep 2012, 35(7):957-965.
51. Woodward S.H., Arsenault N.J., Murray C., et al. Laboratory sleep correlates of nightmare complaint in PSTD inpatients. Biol Psychiatry 2000, 48:1081-1087.
52. Hurwitz T.D., Mahowald M.W., Kuskowski M., et al. Polysomnographic sleep is not clinically impaired in Vietnam combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry 1998, 44:1066-1073.
53. Krystal A.D., Edinger J.D., Wohlgemuth W.K., et al. NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep 2002, 25(6):630-640.
54. Krystal A.D., Edinger J.D. Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia. Sleep 2010, 33(5):669-677.
55. Breslau N. The epidemiology of posttraumatic stress disorder: what is the extent of the Problem?. J Clin Psychiatry 2001, 62(Suppl 17):16-22.
56. Doi Y., Minowa M., Uchiyama M., et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res 2000, 97(2-3):165-172.
57. Hofstetter J.R., Mayeda A.R., Happel C.G., et al. Sleep and daily activity preferences in schizophrenia: associations with neurocognition and symptoms. J Nerv Ment Dis 2003, 191(6):408-410.
58. Hofstetter J.R., Lysaker P.H., Mayeda A.R. Quality of sleep in patients with schizophrenia is associated with quality of life and coping. BMC Psychiatry 2005, 5(13):1-5.
59. Van Kammen D.P., Van Kammen W.B., Peters J.L., et al. CSF MHPG, sleep and psychosis in schizophrenia. Clin Neuropharmacol 1986, 9(Suppl 4):575-577.
60. Van Kammen D.P., Van Kammen W.M., Peters J., et al. Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia. Neuropsychopharmacology 1988, 1:265-271.
61. Martin J.L., Jeste D.V., Ancoli-Israel S. Older schizophrenia patients have more disrupted sleep and circadian rhythms than age-matched comparison subjects. J Psychiatr Res 2005, 39(3):251-259.
62. Chouinard S., Poulin J., Stip E., et al. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull 2004, 30(4):957-967.
63. Caldwell D.F., Domino E.F. Electroencephalographic and eye movement patterns during sleep in chronic schizophrenia patients. Electroencephalogr Clin Neurophysiol 1967, 22:414-420.
64. Poulin J., Daoust A.M., Forest G., et al. Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. Schizophr Res 2003, 62(1-2):147-153.
65. Feinberg I., Braum N., Koresko R.L., et al. Stage 4 sleep in schizophrenia. Arch Gen Psychiatry 1969, 21:262-266.
66. Hiatt J.F., Floyd T.C., Katz P.H., et al. Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia. Arch Gen Psychiatry 1985, 42:797-802.
67. Jus K., Bouchard M., Jus A.K., et al. Sleep EEG studies in untreated long-term schizophrenic patients. Arch Gen Psychiatry 1973, 29:386-390.
68. Keshaven M.S., Reynolds C.F., Miewald J., et al. Slow-wave sleep deficits and outcome in schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 1995, 91(5):289-292.
69. Keshavan M.S., Miewald J., Haas G., et al. Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders. J Psychiatr Res 1995, 29:303-314.
70. Stern M., Fram D., Wyatt R., et al. All night sleep studies of acute schizophrenics. Arch Gen Psychiatry 1969, 20:470-477.
71. Tandon R., Shipley J.E., Taylor S., et al. Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry 1992, 49(3):185-194.
72. Zarcone V.P., Benson K.L., Berger P.A. Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry 1987, 44:45-48.
73. Benson K.L., Zarcone V.P. Sleep abnormalities in schizophrenia and other psychotic disorders. Review of psychiatry 1994, vol. 13:677-705. American Psychiatric Press, Washington, DC.
74. Baekeland F., Lundwall L., Shanahan T.J., et al. Clinical correlates of reported sleep disturbance in alcoholics. Q J Stud Alcohol 1974, 35:1230-1241.
75. Brower K.J., Aldrich M.S., Robinson E.A., et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry 2001, 158:399-404.
76. Brower K.J. Insomnia, alcoholism and relapse. Sleep Med Rev 2003, 7(6):523-539.
77. Lobo L.L., Tufik S. Effects of alcohol on sleep parameters of sleep-deprived healthy volunteers. Sleep 1997, 20:52-59.
78. Gillin J.C., Drummond S.P. Medication and substance abuse. Principles and practice of sleep medicine 2000, 1176-1195. W.B. Saunders. 3rd edition. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
79. Adamson J., Burdick J.A. Sleep of dry alcoholics. Arch Gen Psychiatry 1973, 28:146-149.
80. Drummond S.P., Gillin J.C., Smith T.L., et al. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res 1998, 22:1796-1802.
81. Breslau N., Roth T., Rosenthal L., et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiologic study of young adults. Biol Psychiatry 1996, 39:411-418.
82. Mellinger G.D., Balter M.B., Uhlenhuth E.H. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985, 42:225-232.
83. Ford D.E., Kamerow D.B. Epidemiologic study of sleep disturbance and psychiatric disorders: an opportunity for prevention?. JAMA 1989, 262:1479-1484.
84. Livingston G., Blizard B., Mann A. Does sleep disturbance predict depression in elderly people? A study in inner London. Br J Gen Pract 1993, 43:445-448.
85. Chang P.P., Ford D.E., Mead L.A., et al. Insomnia in young men and subsequent depression. Am J Epidemiol 1997, 146:105-114.
86. Koren D., Arnon I., Lavie P., et al. Sleep complaints as early predictors of posttraumatic stress disorder: a 1-year prospective study of injured survivors of motor vehicle accidents. Am J Psychiatry 2002, 159(5):855-857.
87. Zarcone V.P., Benson K.L. BPRS symptom factors and sleep variables in schizophrenia. Psychiatry Res 1997, 66:111-120.
88. Chemerinski E., Ho B.C., Flaum M., et al. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Compr Psychiatry 2002, 43(5):393-396.
89. Weissman M.M., Greenwald S., Nino-Murcia G., et al. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997, 19(4):245-250.
90. Nierenberg A.A., Keefe B.R., Leslie V.C., et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999, 60:221-225.
91. Roehrs T., Papineau K., Rosenthal L., et al. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood. Neuropsychopharmacology 1999, 20(3):279-286.
92. Skoloda T.E., Alterman A.I., Gottheil E. Sleep quality reported by drinking and non-drinking alcoholics. Addiction research and treatment 1979, 102-112. Pergamon Press, New York. E.L. Gottheil, N.Y. Elmsford (Eds.).
93. NIH Consensus conference. Drugs and insomnia. The use of medications to promote sleep. JAMA 1984, 11(251):2410-2414.
94. Carney C.E., Segal Z.V., Edinger J.D., et al. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry 2007, 68(2):254-260.
95. Reynolds C.F., Frank E., Houck P.R., et al. Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication?. Am J Psychiatry 1997, 154:958-962.
96. Asnis G.M., Chakraburtty A., DuBoff E.A., et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry 1999, 60:668-676.
97. Agargun M.Y., Kara H., Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry 1997, 58:249-251.
98. Agargun M., Kara H., Solmaz M. Subjective sleep quality and suicidality in patients with major depression. J Psychiatr Res 1997, 31(3):377-381.
99. Agargun M., Cilli A., Kara H., et al. Repetitive and frightening dreams and suicidal behavior in patients with major depression. Compr Psychiatry 1998, 39(4):198-202.
100. Agargun M.Y., Besiroglu L., Cilli A.S., et al. Nightmares, suicide attempts, and melancholic features in patients with unipolar major depression. J Affect Disord 2007, 98:267-270.
101. Choquet M., Menke H. Suicidal thoughts during early adolescence: prevalence, associated troubles and help-seeking behavior. Acta Psychiatr Scand 1989, 81:170-177.
102. Choquet M., Kovess V. Suicidal thoughts among adolescents: an intercultural approach. Adolescence 1993, 28(111):649-661.
103. McCall W.V., Blocker J.N., D'Agostino R., et al. Insomnia severity is an indicator of suicidal ideation during a depression clinical trial. Sleep Med 2010, 11(9):822-827.
104. Bernert R., Joiner T., Cukrowicz K., et al. Suicidality and sleep disturbances. Sleep 2005, 28(9):1135-1141.
105. Chellappa S.L., Araújo J.F. Sleep disorders and suicidal ideation in patients with depressive disorder. Psychiatry Res 2007, 153:131-136.
106. Fawcett J., Scheftner W.A., Fogg L., et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990, 147:1189-1194.
107. Vignau J., Bailly D., Duhamel A., et al. Epidemiologic study of sleep quality and troubles in French secondary school adolescents. J Adolesc Health 1997, 21:343-350.
108. Sjöström N., Waern M., Hetta J. Nightmares and sleep disturbances in relation to suicidality in suicide attempters. Sleep 2007, 30:91-95.
109. Smith M., Perlis M., Haythornthwaite J. Suicidal ideation in outpatients with chronic musculoskeletal pain. Clin J Pain 2004, 20(2):111-118.
110. Roberts R., Roberts C., Chen I. Functioning of adolescents with symptoms of disturbed sleep. J Youth Adolesc 2001, 30(1):1-18.
111. Tanskanen A., Tuomilehto J., Vinamaki H., et al. Nightmares are predictors of suicide. Sleep 2001, 24(7):844-847.
112. Turvey C.L., Conwell Y., Jones M.P., et al. Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry 2002, 10:398-406.
113. Oquendo M.A., Mann J.J. Intervention research for suicidal behaviour. Lancet 2003, 362(9387):844-845.
114. Buysse D., Reynolds C.F., Houck P.R., et al. Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy?. J Clin Psychiatry 1997, 58(10):426-432.
115. Dew M., Reynolds C.F., Houck P.R., et al. Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 1997, 54(11):1016-1024.
116. Thase M., Buysse D.J., Frank E., et al. Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles. Am J Psychiatry 1997, 154(4):502-509.
117. Winokur A., Reynolds C.F. The effects of antidepressants and anxiolytics on sleep physiology. Prim Psychiatr 1994, 1:22-27.
118. McCall W.V., Reboussin B.A., Cohen W. Subjective measurement of insomnia and quality of life in depressed inpatients. J Sleep Res 2000, 9:43-48.
119. Nolen W.A., Haffmans P.M., Bouvy P.F., et al. Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant. J Affect Disord 1993, 28:179-188.
120. Fava M., McCall W.V., Krystal A., et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006, 59(11):1052-1060.
121. Krystal A., Fava M., Rubens R., et al. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. J Clin Sleep Med 2007, 3(1):48-55.
122. Fava M., Asnis G.M., Shrivastava R.K., et al. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. J Clin Psychiatry 2011, 72(7):914-928.
123. Manber R., Edinger J.D., Gress J.L., et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008, 31(4):489-495.
124. Wehr T.A. Sleep loss as a possible mediator of diverse causes of mania. Br J Psychiatry 1991, 159:576-578.
125. Wehr T.A., Goodwin F.K., Wirz-Justice A., et al. 48-hour sleep-wake cycles in manic-depressive illness: naturalistic observations and sleep deprivation experiments. Arch Gen Psychiatry 1982, 39:559-565.
126. Zimanova J., Vojtechovsky M. Sleep deprivation as a potentiation of antidepressant pharmacotherapy. Act Nerv Super (Praha) 1974, 16:188-189.
127. Fava M., Asnis G.M., Shrivastava R., et al. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. J Clin Psychopharmacol 2009, 29(3):222-230.
128. Pollack M., Kinrys G., Krystal A., et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 2008, 65(5):551-562.
129. Germain A., Richardson R., Moul D.E., et al. Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans. J Psychosom Res 2012, 72(2):89-96.
130. Pollack M.H., Hoge E.A., Worthington J.J., et al. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2011, 72(7):892-897.
131. Raskind M.A., Peskind E.R., Kanter E.D., et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 2003, 160(2):371-373.
132. Taylor F.B., Martin P., Thompson C., et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry 2008, 63(6):629-632.
133. Raskind M.A., Peskind E.R., Hoff D.J., et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry 2007, 61(8):928-934.
134. Taylor F.B., Lowe K., Thompson C., et al. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biol Psychiatry 2006, 59(7):577-581.
135. Lauer C.J., Schreiber W., Pollmacher T., et al. Sleep in schizophrenia: a polysomnographic study on drug-naïve patients. Neuropsychopharmacology 1997, 16:51-60.
136. Neylan T.C., Van Kammen D.P., Kelley M.E., et al. Sleep in schizophrenic patients on and off haloperidol therapy. Arch Gen Psychiatry 1992, 49:643-649.
137. Benson K.L., Zarcone V.P. REM sleep eye movement activity in schizophrenia and depression. Arch Gen Psychiatry 1993, 50:474-482.
138. Taylor S.F., Tandon R., Shipley J.E., et al. Sleep-onset REM periods in schizophrenic patients. Biol Psychiatry 1991, 30:205-209.
139. Keshavan M.S., Reynolds C.F., Montrose D., et al. Sleep and suicidality in psychotic patients. Acta Psychiatr Scand 1994, 89:122-125.
140. Lewis C.F., Tandon R., Shipley J.E., et al. Biological predictors of suicidality in schizophrenia. Acta Psychiatr Scand 1996, 94:416-420.
141. Foster J.H., Peters T.J. Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome. Alcohol Clin Exp Res 1999, 23(6):1044-1051.
142. Allen R.P., Wagman A.M., Funderburk F.R., et al. Slow wave sleep: a predictor of individual differences in response to drinking?. Biol Psychiatry 1980, 15:345-348.
143. Gillin J.C., Smith T.L., Irwin M., et al. Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry 1994, 51:189-197.
144. Brower K.J., Aldrich M.S., Hall J.M. Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res 1998, 22:1864-1871.
145. Le Bon O., Murphy J.R., Staner L., et al. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol 2003, 23(4):377-383.
146. Brower K.J., Myra Kim H., Strobbe S., et al. Randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res 2008, 32(8):1429-1438.
147. Bowers M., Kupfer D.J. Central monoamine oxidase inhibition and REM sleep. Brain Res 1971, 35:561-564.
148. Wyatt R.J., Fram D.H., Buchbinder R., et al. Treatment of intractable narcolepsy with a monoamine oxidase inhibitor. N Engl J Med 1971, 285:987-991.
149. Wyatt R.J., Fram D.H., Kupfer D.J., et al. Total prolonged drug-induced REM sleep suppression in anxious-depressed patients. Arch Gen Psychiatry 1971, 24:145-155.
150. Gillin J.C., Wyatt R.J., Fram D., et al. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology (Berl) 1978, 59:267-272.
151. Kupfer D.J., Spiker D.G., Coble P.A., et al. Sleep and treatment prediction in endogenous depression. Am J Psychiatry 1981, 138:429-434.
152. Thase M.E. Depression and sleep: pathophysiology and treatment. Dialogues Clin Neurosci 2006, 8:217-226.
153. Mayers A.G., Baldwin D.S. Antidepressants and their effect on sleep. Hum Psychopharmacol 2005, 20:533-559.
154. Krystal A.D., Thase M.E., Tucker V.L., et al. Bupropion HCL and sleep in patients with depression. Clin Psych Rev Current Psychiatry Reviews 2007, 3:123-128.
155. Scharf M.B., Sachais B.A. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry 1990, 51:13-17.
156. Mouret J., Lemoine P., Minuit M.P., et al. Effects of trazodone on the sleep of depressed subjects-a polygraphic study. Psychopharmacology 1988, 95:37-43.
157. Winokur A., Sateia M.J., Hayes J.B., et al. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study. Biol Psychiatry 2000, 48(1):75-78.
158. Winokur A., DeMartinis N.A., McNally D.P. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry 2003, 64(10):1224-1229.
159. Parrino L., Spaggiari M.C., Boselli M., et al. Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia. Psychopharmacology 1994, 116:389-395.
160. Ware J.C., Pittard J.T. Increased deep sleep after trazodone use: a double-blind placebo- controlled study in healthy young adults. J Clin Psychiatry 1990, 51(Suppl):18-22.
161. Krystal A.D., Lankford A., Durrence H.H., et al. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep 2011, 34(10):1433-1442.
162. Krystal A.D., Durrence H.H., Scharf M., et al. Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 2010, 33(11):1553-1561.
163. Scharf M., Rogowski R., Hull S., et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry 2008, 69(10):1557-1564.
164. Roth T., Rogowski R., Hull S., et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep 2007, 30(11):1555-1561.
165. Roth T., Zorick F., Wittig R., et al. The effects of doxepin HCl on sleep and depression. J Clin Psychiatry 1982, 43(9):366-368.
166. Feuillade P., Pringuey D., Belugou J.L., et al. Trimipramine: acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord 1992, 24:135-145.
167. Hajak G., Rodenbeck A., Voderholzer U., et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001, 62(6):453-463.
168. Hohagen F., Montero R.F., Weiss E. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics?. Eur Arch Psychiatry Clin Neurosci 1994, 244(2):65-72.
169. Riemann D., Voderholzer U., Cohrs S., et al. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 2002, 35(5):165-174.
170. Hartmann E., Cravens J. The effects of long term administration of psychotropic drugs on human sleep, IV: the effects of chlorpromazine. Psychopharmacology (Berl) 1973, 33:203-218.
171. Ruigt G.S., Kemp B., Groenhout C.M., et al. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 1990, 38:551-554.
172. Hoque R., Chesson A.L. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 2010, 6(1):79-83.
173. Yang C., White D.P., Winkelman J.W. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005, 58:510-514.
174. Kupfer D.J., Reynolds C.F., Weiss B.L., et al. Lithium carbonate and sleep in affective disorders: further considerations. Arch Gen Psychiatry 1974, 30:79-84.
175. Terao T., Terao M., Yoshimura R., et al. Restless legs syndrome induced by lithium. Biol Psychiatry 1991, 30:1167-1170.
176. Krystal A.D., Goforth H., Roth T. Effects of antipsychotic medications on sleep in schizophrenia. Int Clin Psychopharmacol 2008, 23:150-160.
177. Cohrs S., Rodenbeck A., Guan Z., et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology 2004, 174:421-429.
178. Cohrs S., Meier A., Neumann A.C., et al. Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects. J Clin Psychiatry 2005, 66:989-996.
179. Salin-Pascual R.J., Herrera-Estrella M., Galicia-Polo L., et al. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 1999, 46(1):141-143.
180. Salin-Pascual R.J., Herrera-Estrella M., Galicia-Polo L., et al. Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients. Rev Invest Clin 2004, 56:345-350.
181. Sharpley A.L., Vassallo C.M., Cowen P.J. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2C receptors in vivo. Biol Psychiatry 2000, 47(5):468-470.
182. Sharpley A.L., Vassallo C.M., Pooley E.C. Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine. Psychopathology 2001, 153:271-272.
183. Sharpley A.L., Attenburrow M.E., Hafizi S., et al. Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients. J Clin Psychiatry 2005, 66(4):450-454.
184. Gimenez S., Clos S., Romero S., et al. Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers. Psychopharmacology 2007, 190(4):507-516.
185. Lindberg N., Virkkunen M., Tani P., et al. Effect of a single-dose of olanzapine on sleep in healthy females and males. Int Clin Psychopharmacol 2002, 17(4):177-184.
186. Moreno R.A., Hanna M.M., Tavares S.M., et al. A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania. Braz J Med Biol Res 2007, 40(3):357-366.
187. Hinze-Selch D., Mullington J., Orth A., et al. Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry 1997, 42:260-266.
188. Lee J.H., Woo J.I., Meltzer H.Y. Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia. Psychiatry Res 2001, 103:157-166.
189. Sharpley A.L., Bhagwagar Z., Hafizi S., et al. Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. J Clin Psychiatry 2003, 64:192-196.
190. Staner L., Boeijinga P., Danel T., et al. Effects of acamprosate on sleep during alcohol withdrawal: a double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res 2006, 30(9):1492-1499.
191. Pflug B., Tolle R. Disturbance of the 24-hour rhythm in endogenous depression by sleep deprivation. Int Pharmacopsychiatry 1971, 6:187-196.
192. Post R.M., Kotin J., Goodwin F.K. Effects of sleep deprivation on mood and central amine metabolism in depressed patients. Arch Gen Psychiatry 1976, 33:627-632.
193. Van den Burg W., Van den Hoofdakker R.H. Total sleep deprivation on endogenous depression. Arch Gen Psychiatry 1975, 32:1121-1125.
194. Weigand M., Berger M., Zulley J., et al. The influence of daytime naps on the therapeutic effect of sleep deprivation. Biol Psychiatry 1987, 22:386-389.
195. Sack D.A., Dancan W., Rosenthal N.E., et al. The timing and duration of sleep in partial sleep deprivation therapy of depression. Acta Psychiatr Scand 1988, 77:219-224.
196. Berger M., Vollmann J., Hohagen F., et al. Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients. Am J Psychiatry 1997, 154:870-872.
197. Vogel G.W., Thurmond A., Gibbons P., et al. REM sleep reduction effects on depressive syndromes. Arch Gen Psychiatry 1975, 32:765-777.